Cited by

• Limited role for surveillance PET-CT scanning in patients with diffuse large B-cell lymphoma in complete metabolic remission following primary therapy.

  Cheah CY, Hofman MS, Dickinson M, Wirth A, Westerman D, Harrison SJ, Burbury K, Wolf M, Januszewicz H, Herbert K, Prince HM, Carney DA, Ritchie DS, Hicks RJ, Seymour JF. Cheah CY, et al. Br J Cancer. 2013 Jul 23;109(2):312-7. doi: 10.1038/bjc.2013.338. Epub 2013 Jun 27. Br J Cancer. 2013. PMID: 23807169 Free PMC article.
• CtBP2 Regulates Wnt Signal Through EGR1 to Influence the Proliferation and Apoptosis of DLBCL Cells.

  Dong J, Li L, Zhang X, Yin X, Chen Z. Dong J, et al. Mol Carcinog. 2025 Jun;64(6):959-969. doi: 10.1002/mc.23901. Epub 2025 Mar 18. Mol Carcinog. 2025. PMID: 40099624 Free PMC article.
• Therapeutic Options in Diffuse Large B-Cell Lymphoma - A Retrospective Study and Review of the Literature.

  Patrascu AM, Nacea J, Patrascu Ş, Goganau A, Delcea F, Mogoanta L, Rotaru I. Patrascu AM, et al. Curr Health Sci J. 2017 Jul-Sep;43(3):269-274. doi: 10.12865/CHSJ.43.03.15. Epub 2017 Sep 28. Curr Health Sci J. 2017. PMID: 30595888 Free PMC article.
• MiRNA-363-3p/DUSP10/JNK axis mediates chemoresistance by enhancing DNA damage repair in diffuse large B-cell lymphoma.

  Zhou W, Xu Y, Zhang J, Zhang P, Yao Z, Yan Z, Wang H, Chu J, Yao S, Zhao S, Yang S, Guo Y, Miao J, Liu K, Chan WC, Xia Q, Liu Y. Zhou W, et al. Leukemia. 2022 Jul;36(7):1861-1869. doi: 10.1038/s41375-022-01565-6. Epub 2022 Apr 29. Leukemia. 2022. PMID: 35488020 Free PMC article.
• Prognostic analysis of CD5 expression in double-hit diffuse large B-cell lymphoma and effectiveness comparison in patients treated with dose-adjusted EPOCH plus rituximab/R-CHOP regimens.

  Zhang F, Li L, Zhang L, Li X, Fu X, Wang X, Wu J, Sun Z, Kong F, Ren L, Zhang M. Zhang F, et al. Blood Lymphat Cancer. 2019 Aug 19;9:33-43. doi: 10.2147/BLCTT.S216292. eCollection 2019. Blood Lymphat Cancer. 2019. PMID: 31692510 Free PMC article.